Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,301 to 1,320 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future. | Front Oncol | 2022 | 35860578 | PubTator, text mining | PubMed |
| Neutrophils: New Critical Regulators of Glioma. | Front Immunol | 2022 | 35860278 | PubTator, text mining | PubMed |
| Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma. | Curr Opin Oncol | 2022 | 35855503 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T cell: A cancer immunotherapy. | Indian J Pharmacol | 2022 | 35848695 | PubTator, text mining | PubMed |
| Identification of Potential Antigens for Developing mRNA Vaccine for Immunologically Cold Mesothelioma. | Front Cell Dev Biol | 2022 | 35846349 | PubTator, text mining | PubMed |
| The m7G-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumour Immune Infiltration in Colon Cancer. | Front Genet | 2022 | 35846130 | PubTator, text mining | PubMed |
| Discovery of Notch Pathway-Related Genes for Predicting Prognosis and Tumor Microenvironment Status in Bladder Cancer. | Front Genet | 2022 | 35846128 | PubTator, text mining | PubMed |
| SARS-CoV-2-Induced Immunosuppression: A Molecular Mimicry Syndrome. | Glob Med Genet | 2022 | 35846107 | PubTator, text mining | PubMed |
| Current landscape of gene-editing technology in biomedicine: Applications, advantages, challenges, and perspectives. | MedComm (2020) | 2022 | 35845351 | PubTator, text mining | PubMed |
| TNFR2 Costimulation Differentially Impacts Regulatory and Conventional CD4+ T-Cell Metabolism. | Front Immunol | 2022 | 35844585 | PubTator, text mining | PubMed |
| SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer. | Front Immunol | 2022 | 35844556 | PubTator, text mining | PubMed |
| Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer. | Front Immunol | 2022 | 35844502 | PubTator, text mining | PubMed |
| Hypoxia, a dynamic tool to amplify the gingival mesenchymal stem cells potential for neurotrophic factor secretion. | Saudi J Biol Sci | 2022 | 35844419 | PubTator, text mining | PubMed |
| Antitumor CAR T-cell Screening Platform: Many Are Called, but Few Are Chosen. | Cancer Res | 2022 | 35844172 | PubTator, text mining | PubMed |
| Additive Effect of CD73 Inhibitor in Colorectal Cancer Treatment With CDK4/6 Inhibitor Through Regulation of PD-L1. | Cell Mol Gastroenterol Hepatol | 2022 | 35843546 | PubTator, text mining | PubMed |
| Emerging strategies to overcome resistance to third-generation EGFR inhibitors. | J Hematol Oncol | 2022 | 35840984 | PubTator, text mining | PubMed |
| The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. | Nat Commun | 2022 | 35840578 | PubTator, text mining | PubMed |
| Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma. | Front Oncol | 2022 | 35837094 | PubTator, text mining | PubMed |
| Hub Gene Screening and Prognostic Modeling of Lung Cancer: An Integrated Bioinformatics Study. | Comput Math Methods Med | 2022 | 35836920 | PubTator, text mining | PubMed |
| A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma. | Biol Proced Online | 2022 | 35836132 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=66